Low Risk for Recurrence of Differentiated Thyroid Cancer:  A Paradigm Shift to De-Escalation and Simplifying Care for Long Term Follow-up. Canadian Diabetes & Endocrinology Today, [S. l.], v. 4, n. 2, p. 22–28, 2026. DOI: 10.58931/cdet.2026.4256. Disponível em: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-2-Riar. Acesso em: 27 aug. 2026.